Evidence map›Paper›PMID 37091125›Full record

ArticleACS sustainable chemistry & engineering2023

Vanillin-Based Epoxy Vitrimers: Looking at the Cystamine Hardener from a Different Perspective.

Solène Guggari, Fiona Magliozzi, Samuel Malburet, Alain Graillot, Mathias Destarac, Marc Guerre

Abstract read
In one paragraph

Article in ACS sustainable chemistry & engineering, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Solène GuggariLaboratoire des IMRCP, CNRS UMR 5623, Université de Toulouse, Université Paul Sabatier, 118 Route de Narbonne, 31062 Toulouse Cedex 9, France.
Fiona MagliozziSPECIFIC POLYMERS, Zac Via Domita, 150 Avenue des Cocardières, 34160 Castries, France.
Samuel MalburetSPECIFIC POLYMERS, Zac Via Domita, 150 Avenue des Cocardières, 34160 Castries, France.ORCID https://orcid.org/0000-0002-4224-9520
Alain GraillotSPECIFIC POLYMERS, Zac Via Domita, 150 Avenue des Cocardières, 34160 Castries, France.
Mathias DestaracLaboratoire des IMRCP, CNRS UMR 5623, Université de Toulouse, Université Paul Sabatier, 118 Route de Narbonne, 31062 Toulouse Cedex 9, France.ORCID https://orcid.org/0000-0002-9718-2239
Marc GuerreLaboratoire des IMRCP, CNRS UMR 5623, Université de Toulouse, Université Paul Sabatier, 118 Route de Narbonne, 31062 Toulouse Cedex 9, France.ORCID https://orcid.org/0000-0003-1410-9923

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epoxy vitrimers encompass many advantages compared to traditional epoxy materials such as recyclability, repairability, and reprocessability. These properties are induced by the incorporation of dynamic reversible covalent bonds. Recently, the incorporation of aromatic disulfide bridges that are dynamic has expanded the development of new eco-friendly epoxy materials. Herein, we studied a bio-based aliphatic disulfide based on cystamine as a hardener with a vanillin-derived bio-sourced epoxy to prepare fully bio-based epoxy vitrimers. This article provides a comparative study between cystamine and an aromatic disulfide benchmark hardener issued from petrol resources. This work demonstrated that the presence of this aliphatic hardener has a significant influence not only on the reactivity, but most importantly on the resulting dynamic properties. An interesting yet counterintuitive accelerating effect of the dynamic exchanges was clearly demonstrated with only 2 to 20% of molar fraction of cystamine added to the aromatic disulfide formulation. A similar glass transition was obtained compared to the purely aromatic analogue, but relaxation times were decreased by an order of magnitude.

Identifiers

PMID37091125
PMCPMC10114092

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.